Dr. Quesada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Ste 722
Houston, TX 77030Phone+1 832-325-6520Fax+1 713-500-0730
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1977 - 1980
Universidad Nacional Autonoma de MexicoClass of 1973
Certifications & Licensure
TX State Medical License 1979 - 2024- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Publications & Presentations
PubMed
- 10 citationsAcute myelofibrosis and acute lymphoblastic leukemia in an elderly patient with previously treated multiple myeloma.Maria M. Gonzalez, Laura Kidd, Jorge R. Quesada, Nghia D. Nguyen, Lei Chen
Annals of Clinical and Laboratory Science. 2013-03-20 - 9 citationsMorphoproteomic study of primary pleural angiosarcoma of lymphangioendothelial lineage: a case report.Andres E. Quesada, Jorge R. Quesada, Kamal G. Khalil, Emma C. Ferguson, Robert E. Brown
Annals of Clinical and Laboratory Science. 2013-06-20 - 476 citationsClinical toxicity of interferons in cancer patients: a review.Jorge R. Quesada, Moshe Talpaz, Adan Rios, Razelle Kurzrock, Jordan U. Gutterman
Journal of Clinical Oncology. 1986-02-01
Press Mentions
Cancer Immunotherapy: Breakthrough or “Deja Vu, All over Again”?June 22nd, 2017
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
